Home›Companies›Biotech & Pharma›OrsoBio

OrsoBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 28, 2024·Suggest an edit

About OrsoBio

OrsoBio is a private company based in Menlo Park, California, incorporated in 2020 in Delaware. It has reported $124,629,383 raised in two offerings on Form D since November 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 14, 2024Aug 28, 2024$40,000,000of $67.0M target7$5.7MEquityRule 506(b)Form D ↗
Oct 27, 2023Nov 13, 2023$84,629,383fully sold6$14.1MEquityRule 506(b)Form D ↗
Total, two offerings$124,629,383

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OrsoBio's Form D filed Aug 28, 2024.

MY
MS
Mani Subramanian
Executive officer and director
CF
EF
ER
Evan Rachlin
Director
GG
Gangadhara Ganapati
Secretary and director

Sources

  1. SECOrsoBio, Inc. filing history